Therapeutic Response: How to Select a Preventive Migraine Treatment

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Addressing Therapeutic Response: How to Select a Preventive Migraine Treatment



ReachMD Healthcare Image

With so many options out there, which migraine treatment would you consider? 

  • Overview

    A patient is referred to you for the treatment and management of their migraine. With so many options out there, which one would you consider? Joining us to talk about a treatment option is Dr. Jessica Ailani.


    AJOVY® (fremanezumab-vfrm) injection is indicated for the preventive treatment of migraine in adults. 


    Contraindications: AJOVY is contraindicated in patients with serious hypersensitivity to fremanezumab-vfrm or to any of the excipients. Reactions have included anaphylaxis and angioedema.

    Hypersensitivity Reactions: Hypersensitivity reactions, including rash, pruritus, drug hypersensitivity, and urticaria were reported with AJOVY in clinical trials. Most reactions were mild to moderate, but some led to discontinuation or required corticosteroid treatment. Most reactions were reported from within hours to one month after administration. Cases of anaphylaxis and angioedema have been reported in the postmarketing setting. If a hypersensitivity reaction occurs, consider discontinuing AJOVY and institute appropriate therapy.

    Adverse Reactions: The most common adverse reactions in clinical trials (≥5% and greater than placebo) were injection site reactions.

    Please see the full Prescribing Information for AJOVY.

    Sponsored by Teva Pharmaceuticals USA, Inc. FRE-44402 12/22 | Mobile: FRE-44422 12/22

Schedule31 Mar 2023